Header Logo

Andrew Ambrosy

Concepts (430)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
110
2023
398
22.870
Why?
Stroke Volume
43
2022
101
5.480
Why?
Hospitalization
54
2022
805
5.320
Why?
Humans
136
2023
17707
2.860
Why?
Natriuretic Peptide, Brain
16
2022
27
2.730
Why?
Angiotensin Receptor Antagonists
12
2022
53
2.510
Why?
Neprilysin
6
2020
10
2.360
Why?
Aged
68
2022
6150
2.130
Why?
Benzazepines
13
2016
24
2.120
Why?
Digoxin
5
2022
12
2.120
Why?
Aminobutyrates
10
2020
18
2.060
Why?
Acute Disease
16
2023
141
1.940
Why?
Tetrazoles
10
2020
15
1.920
Why?
Male
77
2022
10094
1.870
Why?
Female
82
2022
12729
1.780
Why?
Registries
14
2022
470
1.750
Why?
Treatment Outcome
37
2022
1254
1.680
Why?
Antidiuretic Hormone Receptor Antagonists
10
2016
11
1.570
Why?
Ventricular Function, Left
11
2022
52
1.540
Why?
Middle Aged
55
2022
7976
1.530
Why?
Prognosis
31
2021
613
1.440
Why?
Cardiovascular Diseases
3
2021
596
1.390
Why?
Atherosclerosis
2
2021
53
1.390
Why?
Patient Readmission
11
2020
164
1.350
Why?
Peptide Fragments
9
2020
27
1.330
Why?
Angiotensin-Converting Enzyme Inhibitors
9
2022
86
1.320
Why?
Disease Progression
12
2022
266
1.290
Why?
Inpatients
7
2018
81
1.200
Why?
Health Status
5
2020
299
1.160
Why?
Exercise Therapy
2
2018
71
1.070
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2021
172
1.040
Why?
Delivery of Health Care, Integrated
2
2022
531
1.020
Why?
Cardiotonic Agents
7
2020
12
1.020
Why?
Quality of Life
7
2022
521
1.000
Why?
Dyspnea
6
2020
48
0.920
Why?
Renin-Angiotensin System
3
2022
17
0.920
Why?
Prospective Studies
20
2021
1287
0.900
Why?
Anemia
3
2020
34
0.880
Why?
Patient Discharge
8
2022
153
0.870
Why?
Liver Diseases
2
2015
23
0.860
Why?
Double-Blind Method
16
2020
160
0.840
Why?
Drug Combinations
8
2020
43
0.830
Why?
Valsartan
5
2020
11
0.830
Why?
Randomized Controlled Trials as Topic
14
2021
327
0.820
Why?
Evidence-Based Medicine
4
2017
179
0.810
Why?
Practice Guidelines as Topic
4
2018
314
0.810
Why?
Thirst
1
2022
1
0.810
Why?
Forecasting
2
2021
74
0.800
Why?
Death, Sudden, Cardiac
3
2020
35
0.790
Why?
Aged, 80 and over
13
2022
1927
0.760
Why?
Enalapril
6
2020
8
0.750
Why?
Clinical Trials as Topic
5
2016
131
0.730
Why?
Eicosapentaenoic Acid
1
2021
9
0.720
Why?
Natriuretic Agents
3
2017
3
0.720
Why?
Platelet Aggregation Inhibitors
1
2021
24
0.710
Why?
Natural Language Processing
1
2021
58
0.710
Why?
Global Health
5
2017
31
0.700
Why?
Exercise Tolerance
1
2020
13
0.690
Why?
Survival Rate
14
2020
262
0.690
Why?
Risk Factors
22
2022
3367
0.690
Why?
Pandemics
6
2022
286
0.680
Why?
Anemia, Iron-Deficiency
1
2020
7
0.680
Why?
Risk Assessment
8
2020
1106
0.660
Why?
United States
20
2023
3914
0.640
Why?
Retrospective Studies
15
2022
2471
0.630
Why?
Network Meta-Analysis
1
2018
3
0.610
Why?
Weight Loss
2
2018
305
0.580
Why?
Liver Function Tests
2
2015
6
0.580
Why?
Follow-Up Studies
16
2021
1218
0.570
Why?
Cause of Death
9
2018
181
0.560
Why?
Substance-Related Disorders
5
2018
420
0.560
Why?
Research Design
3
2021
372
0.550
Why?
Diuretics
4
2022
17
0.550
Why?
Glomerular Filtration Rate
7
2022
154
0.550
Why?
Outpatients
1
2018
107
0.550
Why?
Exercise
2
2020
496
0.540
Why?
Time Factors
13
2020
1095
0.530
Why?
Aspartate Aminotransferases
2
2013
13
0.520
Why?
Alanine Transaminase
2
2013
22
0.520
Why?
Predictive Value of Tests
8
2020
355
0.500
Why?
Blood Pressure
4
2014
300
0.500
Why?
Patient Admission
5
2021
71
0.500
Why?
Defibrillators, Implantable
4
2020
32
0.490
Why?
Weight Gain
1
2017
175
0.480
Why?
Hyponatremia
2
2014
4
0.480
Why?
Research
1
2015
64
0.480
Why?
Health Knowledge, Attitudes, Practice
1
2018
381
0.480
Why?
Outcome and Process Assessment (Health Care)
1
2014
102
0.450
Why?
Dose-Response Relationship, Drug
7
2020
128
0.430
Why?
Relaxin
1
2013
1
0.430
Why?
Endpoint Determination
3
2017
10
0.420
Why?
Emergency Service, Hospital
3
2022
377
0.410
Why?
Diltiazem
1
2012
1
0.410
Why?
Chronic Disease
7
2021
416
0.400
Why?
Deoxycytidine
1
2012
7
0.400
Why?
Adult
14
2022
7658
0.400
Why?
Chest Pain
1
2012
15
0.400
Why?
Fluorouracil
1
2012
11
0.400
Why?
Practice Patterns, Physicians'
1
2014
324
0.380
Why?
Comorbidity
9
2020
590
0.380
Why?
Renal Insufficiency
3
2019
13
0.380
Why?
Analgesics, Opioid
2
2018
243
0.380
Why?
Electrocardiography
5
2015
43
0.370
Why?
Cardiovascular Agents
4
2022
24
0.370
Why?
Heart Function Tests
1
2011
3
0.370
Why?
Hospital Mortality
10
2022
145
0.370
Why?
Patient Selection
4
2017
190
0.360
Why?
Mineralocorticoid Receptor Antagonists
4
2021
10
0.360
Why?
London
2
2020
6
0.350
Why?
Guideline Adherence
4
2017
155
0.350
Why?
Cohort Studies
8
2022
2589
0.340
Why?
Veterans
2
2023
137
0.340
Why?
Liraglutide
2
2020
5
0.330
Why?
Length of Stay
5
2020
182
0.320
Why?
Vascular Diseases
2
2020
4
0.320
Why?
Hemodynamics
2
2020
7
0.320
Why?
Sodium Potassium Chloride Symporter Inhibitors
2
2021
2
0.310
Why?
Ventricular Dysfunction, Left
3
2014
20
0.310
Why?
Surveys and Questionnaires
4
2017
1322
0.310
Why?
Kaplan-Meier Estimate
9
2016
129
0.310
Why?
Prescription Drug Misuse
1
2018
9
0.290
Why?
Disease Management
3
2018
136
0.290
Why?
Triglycerides
2
2021
89
0.280
Why?
Drug Overdose
1
2018
57
0.270
Why?
Systole
3
2017
22
0.270
Why?
Hematocrit
2
2019
6
0.270
Why?
Myocardial Infarction
2
2020
234
0.270
Why?
Marijuana Abuse
1
2017
39
0.270
Why?
Colorectal Neoplasms
1
2012
616
0.260
Why?
Cardio-Renal Syndrome
2
2019
2
0.260
Why?
Marijuana Smoking
1
2016
51
0.250
Why?
Heart Transplantation
2
2022
10
0.250
Why?
Health Services
1
2016
114
0.240
Why?
Animals
4
2014
262
0.240
Why?
Biomarkers
5
2020
312
0.240
Why?
Incidence
6
2020
1269
0.240
Why?
Antihypertensive Agents
3
2022
159
0.230
Why?
Adrenergic beta-Antagonists
3
2014
43
0.230
Why?
Clinical Trials, Phase II as Topic
2
2014
3
0.220
Why?
Echocardiography
2
2014
32
0.210
Why?
Proportional Hazards Models
6
2016
710
0.210
Why?
Opioid-Related Disorders
2
2021
165
0.210
Why?
Primary Prevention
2
2020
70
0.210
Why?
Transcatheter Aortic Valve Replacement
1
2022
2
0.210
Why?
Aortic Valve Stenosis
1
2022
3
0.200
Why?
Atrial Fibrillation
2
2016
171
0.200
Why?
Coronary Angiography
2
2014
19
0.200
Why?
Morbidity
2
2020
59
0.200
Why?
California
5
2020
2327
0.200
Why?
Patient Acceptance of Health Care
1
2016
387
0.200
Why?
Coronavirus Infections
2
2020
48
0.200
Why?
Pneumonia, Viral
2
2020
55
0.200
Why?
Ventricular Dysfunction, Right
1
2022
3
0.200
Why?
Natriuretic Peptides
4
2014
5
0.200
Why?
Acute Coronary Syndrome
1
2022
18
0.200
Why?
Nutritive Value
1
2022
11
0.190
Why?
Canada
2
2021
66
0.190
Why?
Drug Therapy, Combination
2
2021
115
0.190
Why?
Attitude
1
2022
30
0.190
Why?
Amides
2
2018
3
0.190
Why?
Fumarates
2
2018
4
0.190
Why?
Drug-Related Side Effects and Adverse Reactions
1
2022
107
0.190
Why?
Phenotype
2
2019
151
0.180
Why?
Recurrence
4
2020
189
0.180
Why?
Intention to Treat Analysis
1
2021
20
0.180
Why?
India
1
2020
13
0.180
Why?
Treatment Adherence and Compliance
1
2021
12
0.180
Why?
Mitral Valve Insufficiency
1
2020
1
0.180
Why?
Heart Valve Prosthesis Implantation
1
2020
4
0.180
Why?
Coronary Artery Disease
2
2012
133
0.180
Why?
Receptors, Angiotensin
1
2020
3
0.180
Why?
Biphenyl Compounds
1
2020
10
0.180
Why?
Opiate Substitution Treatment
1
2021
42
0.180
Why?
Death
1
2020
10
0.180
Why?
Respiratory Tract Infections
1
2021
48
0.170
Why?
State Health Plans
1
2010
33
0.170
Why?
Analgesics
1
2010
27
0.170
Why?
Kidney Failure, Chronic
1
2022
151
0.170
Why?
Incretins
1
2020
2
0.170
Why?
Longitudinal Studies
5
2017
717
0.170
Why?
Buprenorphine
1
2021
44
0.170
Why?
Europe
3
2017
42
0.170
Why?
Severity of Illness Index
3
2018
448
0.170
Why?
Transferrins
1
2020
4
0.170
Why?
Transferrin
1
2020
5
0.170
Why?
Coronary Vessel Anomalies
1
2020
2
0.170
Why?
Ferritins
1
2020
9
0.170
Why?
Ventricular Fibrillation
1
2020
4
0.170
Why?
Cardiac Output, Low
3
2018
3
0.170
Why?
Tachycardia, Ventricular
1
2020
6
0.170
Why?
Sex Distribution
3
2019
189
0.170
Why?
Accelerometry
1
2020
39
0.170
Why?
ST Elevation Myocardial Infarction
1
2020
6
0.170
Why?
Pain
1
2010
79
0.170
Why?
Galectin 3
1
2019
1
0.170
Why?
Interleukin-1 Receptor-Like 1 Protein
1
2019
3
0.170
Why?
Growth Differentiation Factor 15
1
2019
4
0.170
Why?
Kidney
1
2020
53
0.170
Why?
Population Dynamics
1
2019
6
0.170
Why?
Renal Insufficiency, Chronic
1
2022
181
0.170
Why?
Hemoglobins
1
2020
39
0.170
Why?
Hemofiltration
1
2019
1
0.160
Why?
Hemoglobinometry
1
2019
3
0.160
Why?
Cardiorespiratory Fitness
1
2019
9
0.160
Why?
Recovery of Function
2
2016
27
0.160
Why?
Diet
1
2022
367
0.160
Why?
Pain, Postoperative
2
2009
17
0.160
Why?
Referral and Consultation
1
2020
165
0.160
Why?
Heart Diseases
1
2019
75
0.160
Why?
Spironolactone
1
2019
6
0.160
Why?
Delivery of Health Care
2
2023
397
0.160
Why?
Drug Resistance
1
2019
31
0.160
Why?
Intensive Care Units
2
2021
103
0.150
Why?
Lipids
2
2019
82
0.150
Why?
Tobacco Use Cessation
1
2008
22
0.150
Why?
North America
2
2015
42
0.150
Why?
Adolescent
7
2021
3671
0.150
Why?
Drug Utilization
2
2014
124
0.150
Why?
Hypotension
2
2020
5
0.150
Why?
France
1
2018
12
0.150
Why?
Patient Protection and Affordable Care Act
1
2018
42
0.150
Why?
Age Distribution
2
2019
246
0.150
Why?
Depression
2
2017
504
0.150
Why?
Troponin
1
2017
10
0.140
Why?
Insurance Coverage
1
2018
105
0.140
Why?
Multicenter Studies as Topic
4
2021
85
0.140
Why?
Ventricular Remodeling
1
2017
6
0.140
Why?
Health Policy
1
2018
118
0.140
Why?
Substance Abuse Treatment Centers
3
2008
74
0.140
Why?
Blood Glucose
1
2019
348
0.140
Why?
Self Care
1
2008
164
0.140
Why?
Urine
1
2017
5
0.140
Why?
Atrial Flutter
2
2016
16
0.140
Why?
Algorithms
1
2018
237
0.130
Why?
Clinical Trials, Phase III as Topic
2
2014
3
0.130
Why?
Activities of Daily Living
1
2017
85
0.130
Why?
Patient Dropouts
1
2016
22
0.130
Why?
Private Sector
1
2006
15
0.130
Why?
Vasopressins
2
2012
5
0.130
Why?
Pulmonary Edema
1
2016
2
0.130
Why?
HIV Infections
1
2022
704
0.130
Why?
Asian Continental Ancestry Group
1
2016
90
0.130
Why?
Receptors, Vasopressin
2
2012
2
0.130
Why?
Mortality
1
2016
118
0.120
Why?
Diabetes Mellitus
1
2019
483
0.120
Why?
Primary Health Care
1
2021
756
0.120
Why?
Reference Values
1
2015
93
0.120
Why?
Decision Making
1
2016
182
0.120
Why?
Uric Acid
1
2014
9
0.120
Why?
Hyperlipidemias
1
2014
53
0.120
Why?
Syndrome
2
2011
29
0.110
Why?
Therapies, Investigational
1
2014
1
0.110
Why?
Outcome Assessment (Health Care)
2
2013
227
0.110
Why?
Catheterization, Swan-Ganz
1
2014
2
0.110
Why?
Cardiac Resynchronization Therapy
1
2014
4
0.110
Why?
Vasodilator Agents
1
2014
9
0.110
Why?
Asia
1
2014
15
0.110
Why?
Patient Compliance
1
2006
299
0.110
Why?
Magnesium
1
2013
6
0.110
Why?
ROC Curve
1
2013
77
0.110
Why?
Liver Abscess
1
2013
1
0.110
Why?
Chemoembolization, Therapeutic
1
2013
2
0.100
Why?
Edema, Cardiac
1
2013
1
0.100
Why?
Respiratory Sounds
1
2013
12
0.100
Why?
Arginine Vasopressin
1
2012
2
0.100
Why?
Ambulatory Care
2
2012
241
0.100
Why?
Arrhythmia, Sinus
1
2012
2
0.100
Why?
Carcinoma, Hepatocellular
1
2013
26
0.100
Why?
Lymphocyte Count
1
2012
1
0.100
Why?
Fatigue
1
2013
34
0.100
Why?
Coronary Vasospasm
1
2012
1
0.100
Why?
Capecitabine
1
2012
2
0.100
Why?
Prodrugs
1
2012
2
0.100
Why?
Antimetabolites, Antineoplastic
1
2012
3
0.100
Why?
Calcium Channel Blockers
1
2012
14
0.100
Why?
Cholesterol
1
2012
106
0.100
Why?
Anus Neoplasms
1
2012
26
0.100
Why?
Liver Neoplasms
1
2013
40
0.100
Why?
Secondary Prevention
1
2012
48
0.100
Why?
Heart Failure, Systolic
1
2012
4
0.100
Why?
Neurotransmitter Agents
1
2012
1
0.100
Why?
Albumins
1
2012
6
0.100
Why?
Alkaline Phosphatase
1
2012
7
0.100
Why?
Quality Improvement
1
2014
189
0.100
Why?
Obesity
1
2018
841
0.100
Why?
Carcinoma, Squamous Cell
1
2012
55
0.100
Why?
Analysis of Variance
1
2012
159
0.100
Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2011
1
0.090
Why?
Sodium-Potassium-Exchanging ATPase
1
2011
2
0.090
Why?
Liver Transplantation
1
2011
6
0.090
Why?
Confidence Intervals
1
2012
237
0.090
Why?
End Stage Liver Disease
1
2011
9
0.090
Why?
Diuresis
1
2011
1
0.090
Why?
Toxicity Tests
1
2011
1
0.090
Why?
Disease Models, Animal
1
2011
19
0.090
Why?
Consensus
1
2011
40
0.090
Why?
Adenocarcinoma
1
2012
173
0.090
Why?
Edema
2
2020
5
0.090
Why?
Romania
3
2016
3
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2012
196
0.080
Why?
Headache
1
2010
14
0.080
Why?
Tomography, X-Ray Computed
1
2011
211
0.080
Why?
Analgesia, Patient-Controlled
1
2009
2
0.080
Why?
Percutaneous Coronary Intervention
2
2020
22
0.080
Why?
Analgesia, Epidural
1
2009
4
0.080
Why?
Demography
1
2010
100
0.080
Why?
Anesthesia, Caudal
1
2009
1
0.080
Why?
Groin
1
2009
3
0.080
Why?
Nerve Block
1
2009
3
0.080
Why?
Hernia, Inguinal
1
2009
3
0.080
Why?
Anxiety
2
2016
152
0.080
Why?
Age Factors
3
2014
918
0.080
Why?
Arrhythmias, Cardiac
2
2022
32
0.080
Why?
Women's Health Services
1
2008
16
0.080
Why?
Electronic Health Records
2
2018
694
0.080
Why?
Clinical Protocols
3
2014
42
0.070
Why?
Drug Administration Schedule
2
2018
100
0.070
Why?
Kidney Function Tests
2
2019
22
0.070
Why?
Parents
1
2009
295
0.070
Why?
Creatinine
2
2019
65
0.070
Why?
Prevalence
3
2015
882
0.060
Why?
Sex Factors
2
2014
639
0.060
Why?
Odds Ratio
2
2017
670
0.060
Why?
African Americans
2
2020
465
0.060
Why?
Injections, Intravenous
2
2017
10
0.060
Why?
Aortic Valve
1
2022
4
0.050
Why?
Immunoglobulin Fab Fragments
1
2022
1
0.050
Why?
RNA
1
2022
12
0.050
Why?
Shock, Cardiogenic
1
2022
6
0.050
Why?
Potassium
1
2022
16
0.050
Why?
Meals
1
2022
7
0.050
Why?
Child
4
2010
2481
0.050
Why?
Heart Rate
1
2022
41
0.050
Why?
Heart
1
2022
13
0.050
Why?
United States Department of Veterans Affairs
1
2023
120
0.050
Why?
Aldosterone
1
2022
2
0.050
Why?
Sodium Chloride Symporter Inhibitors
1
2022
9
0.050
Why?
CD4 Lymphocyte Count
1
2022
181
0.050
Why?
Hospitals
1
2022
76
0.050
Why?
Americas
1
2021
2
0.050
Why?
Nurse Administrators
1
2021
6
0.050
Why?
Polymerase Chain Reaction
1
2021
49
0.040
Why?
Mitral Valve
1
2020
2
0.040
Why?
Withholding Treatment
1
2021
26
0.040
Why?
Chicago
2
2011
25
0.040
Why?
Angiotensins
1
2020
3
0.040
Why?
Long-Term Care
1
2010
21
0.040
Why?
Early Termination of Clinical Trials
1
2020
1
0.040
Why?
Heart-Assist Devices
1
2020
2
0.040
Why?
Propensity Score
1
2021
85
0.040
Why?
Pragmatic Clinical Trials as Topic
1
2021
61
0.040
Why?
Glucagon-Like Peptide-1 Receptor
1
2020
3
0.040
Why?
Lung
1
2020
62
0.040
Why?
Feasibility Studies
2
2011
111
0.040
Why?
Electric Countershock
1
2020
16
0.040
Why?
Regression Analysis
2
2012
296
0.040
Why?
Walk Test
1
2019
5
0.040
Why?
Betacoronavirus
1
2020
34
0.040
Why?
Clinical Decision-Making
1
2020
34
0.040
Why?
Heart Arrest
1
2019
34
0.040
Why?
Datasets as Topic
1
2019
20
0.040
Why?
Cost of Illness
1
2020
94
0.040
Why?
Washington
1
2010
382
0.040
Why?
Injections, Subcutaneous
1
2018
4
0.040
Why?
Coronary Disease
1
2019
180
0.040
Why?
Aging
1
2019
163
0.040
Why?
Psychiatric Status Rating Scales
1
2008
123
0.040
Why?
Databases, Factual
1
2020
311
0.040
Why?
Social Environment
1
2008
87
0.040
Why?
Psychometrics
1
2008
122
0.040
Why?
Drug Delivery Systems
1
2018
3
0.040
Why?
Health Care Costs
1
2020
222
0.040
Why?
Alberta
1
2017
3
0.040
Why?
Netherlands
1
2017
7
0.040
Why?
Italy
1
2017
14
0.040
Why?
Administration, Oral
1
2018
84
0.040
Why?
Continental Population Groups
1
2019
301
0.040
Why?
Patient Safety
1
2018
38
0.040
Why?
Motivation
1
2008
130
0.040
Why?
Heart Ventricles
1
2017
17
0.040
Why?
Body Weight
1
2018
226
0.030
Why?
Medicaid
1
2018
188
0.030
Why?
Far East
1
2016
6
0.030
Why?
Asia, Southeastern
1
2016
4
0.030
Why?
Chi-Square Distribution
1
2016
154
0.030
Why?
Body Mass Index
1
2020
970
0.030
Why?
Osmolar Concentration
1
2016
8
0.030
Why?
Linear Models
1
2016
229
0.030
Why?
Hypoglycemic Agents
1
2018
271
0.030
Why?
Triage
1
2015
18
0.030
Why?
Child, Preschool
2
2009
1417
0.030
Why?
Multivariate Analysis
1
2016
561
0.030
Why?
Managed Care Programs
1
2006
313
0.030
Why?
Young Adult
1
2021
2450
0.030
Why?
Logistic Models
1
2016
918
0.030
Why?
Myocardial Ischemia
1
2013
24
0.030
Why?
Rome
1
2013
1
0.030
Why?
Congresses as Topic
1
2013
13
0.030
Why?
Hydrazones
1
2013
1
0.030
Why?
Radiography
1
2013
39
0.030
Why?
Xanthines
1
2013
6
0.030
Why?
Pyridines
1
2013
9
0.030
Why?
Pyridazines
1
2013
6
0.030
Why?
Europe, Eastern
1
2012
1
0.030
Why?
South America
1
2012
4
0.030
Why?
Internationality
1
2012
14
0.030
Why?
Survival Analysis
1
2013
216
0.030
Why?
Ethnic Groups
1
2006
474
0.030
Why?
Diabetes Mellitus, Type 2
1
2019
755
0.020
Why?
European Continental Ancestry Group
1
2014
523
0.020
Why?
Etiocholanolone
1
2011
1
0.020
Why?
Plaque, Atherosclerotic
1
2011
1
0.020
Why?
Models, Biological
1
2011
30
0.020
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2011
7
0.020
Why?
Observer Variation
1
2011
37
0.020
Why?
Asymptomatic Diseases
1
2011
29
0.020
Why?
Calcinosis
1
2011
40
0.020
Why?
Reproducibility of Results
1
2011
371
0.020
Why?
Somatosensory Disorders
1
2010
1
0.020
Why?
Epidemiologic Studies
1
2010
29
0.020
Why?
Disability Evaluation
1
2010
46
0.020
Why?
Statistics as Topic
1
2010
62
0.020
Why?
Postoperative Nausea and Vomiting
1
2009
1
0.020
Why?
Health Surveys
1
2010
260
0.020
Why?
Accreditation
1
2008
5
0.020
Why?
Child Care
1
2008
11
0.020
Why?
Ownership
1
2008
14
0.020
Why?
Methadone
1
2008
10
0.020
Why?
Health Care Surveys
1
2008
223
0.020
Why?
Infant
1
2009
1199
0.020
Why?
Concepts (430)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
-->

© 2025 Kaiser Permanente